An open, randomised, multicentre trial of Tomudex (ZD1694) versus 5-Fluorouracil (5-FU) and Leucovorin (LV) in patients with advanced colorectal carcinoma

Trial Profile

An open, randomised, multicentre trial of Tomudex (ZD1694) versus 5-Fluorouracil (5-FU) and Leucovorin (LV) in patients with advanced colorectal carcinoma

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Raltitrexed (Primary) ; Fluorouracil; Folinic acid
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Sponsors AstraZeneca Pharmaceuticals
  • Most Recent Events

    • 08 Aug 2009 Actual end date (31 Dec 2001), actual initiation date (1 Jan 2000), trial locations (England, Scotland) and lead trial centres added as reported by ISRCTN: Current Controlled Trials.
    • 08 Aug 2009 Status changed from not stated to completed as reported by ISRCTN: Current Controlled Trials.
    • 19 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top